Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis.
Jones AP, Trend S, Byrne SN, Fabis-Pedrini MJ, Geldenhuys S, Nolan D, Booth DR, Carroll WM, Lucas RM, Kermode AG, Hart PH. Jones AP, et al. Among authors: booth dr. Clin Transl Immunology. 2017 May 26;6(5):e143. doi: 10.1038/cti.2017.18. eCollection 2017 May. Clin Transl Immunology. 2017. PMID: 28690849 Free PMC article.
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study.
Hart PH, Jones AP, Trend S, Cha L, Fabis-Pedrini MJ, Cooper MN, d'Este C, Geldenhuys S, Carroll WM, Byrne SN, Booth DR, Cole JM, Lucas RM, Kermode AG. Hart PH, et al. Among authors: booth dr. Mult Scler J Exp Transl Clin. 2018 Apr 27;4(2):2055217318773112. doi: 10.1177/2055217318773112. eCollection 2018 Apr-Jun. Mult Scler J Exp Transl Clin. 2018. PMID: 29780610 Free PMC article.
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome.
Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, Kermode AG, French MA, Hart PH. Trend S, et al. Among authors: booth dr. Front Immunol. 2018 Jul 13;9:1590. doi: 10.3389/fimmu.2018.01590. eCollection 2018. Front Immunol. 2018. PMID: 30057580 Free PMC article.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
McKay FC, Gatt PN, Fewings N, Parnell GP, Schibeci SD, Basuki MA, Powell JE, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Burke T, Vucic S, Stewart GJ, Booth DR. McKay FC, et al. Among authors: booth dr. Clin Immunol. 2016 Feb;163:96-107. doi: 10.1016/j.clim.2015.12.015. Epub 2016 Jan 4. Clin Immunol. 2016. PMID: 26762769
Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditions.
Law SPL, Gatt PN, Schibeci SD, McKay FC, Vucic S, Hart P, Byrne SN, Brown D, Stewart GJ, Liddle C, Parnell GP, Booth DR. Law SPL, et al. Among authors: booth dr. Genes Immun. 2021 Aug;22(4):227-233. doi: 10.1038/s41435-021-00144-6. Epub 2021 Jun 23. Genes Immun. 2021. PMID: 34163021 Free PMC article.
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.
Fewings NL, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR. Fewings NL, et al. Among authors: booth dr. J Autoimmun. 2017 Mar;78:57-69. doi: 10.1016/j.jaut.2016.12.006. Epub 2017 Jan 4. J Autoimmun. 2017. PMID: 28063629
187 results